Group A
In patients with a major discrepancy between the perceiverd level of symptoms and severity of airflow limitation, further evaluation is warranted.
Adapted from: Global Initiative for Chronic Obstructive Lung Disease; 2017.
Group B
In patients with a major discrepancy between the perceiverd level of symptoms and severity of airflow limitation, further evaluation is warranted.
Adapted from: Global Initiative for Chronic Obstructive Lung Disease; 2017.
Group C
In patients with a major discrepancy between the perceiverd level of symptoms and severity of airflow limitation, further evaluation is warranted.
Adapted from: Global Initiative for Chronic Obstructive Lung Disease; 2017.
Group D
In patients with a major discrepancy between the perceiverd level of symptoms and severity of airflow limitation, further evaluation is warranted.
Adapted from: Global Initiative for Chronic Obstructive Lung Disease; 2017.
Nonpharmacological treatment options